###begin article-title 0
###xml 41 59 41 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 and DQB1 </italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: A relationship between HLA and gender is suggested
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 374 378 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 437 445 <span type="species:ncbi:9606">patients</span>
Narcolepsy-cataplexy is characterized by excessive daytime sleepiness with recurrent episodes of irresistible sleep, cataplexy, hallucinations and sleep paralysis. Its aetiology is unknown, but it is positively associated with the human leukocyte antigens (HLA) in all studied populations. The purpose of the present study was to investigate the association of HLA class II DRB1/DQB1 alleles with narcolepsy-cataplexy in Mexican Mestizo patients.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
This is a case-control study of consecutive patients and ethnically matched controls. We included 32 patients diagnosed with typical narcolepsy-cataplexy, of the National Institute of Neurology, of the Institute of Psychiatry and at the Center of Narcolepsy at Stanford University. As healthy controls, 203 Mexican Mestizos were included. DRB1 alleles were identified using sequence based typing. A PCR-SSOP reverse dot blot was used for DQB1 typing. Allele frequency was calculated by direct counting and the significance of the differences was assessed using the Yates Chi square. Odds ratio and confidence intervals were evaluated.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 403 407 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 557 561 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 843 847 843 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
###xml 471 479 <span type="species:ncbi:9606">patients</span>
HLA-DRB1*1501 (OR = 8.2; pc < 0.0001) and DQB1*0602 (OR = 8.4; pc < 0.0001) were found positively associated with narcolepsy. When deleting DQB1*0602+ patients from the analysis, DQB1*0301 was also found increased (OR = 2.7; p = 0.035; pc = NS). DQB1*0602/DQB1*0301 genotype was present in 15.6% of the cases (OR = 11.5; p = 0.00035), conferring a high risk. DRB1*0407 (OR = 0.2; p = 0.016 pc = NS) and DQB1*0302(OR = 0.4; p = 0.017, pc = NS) were found decreased in the patients. The gender stratification analysis showed a higher risk in females carrying DRB1*1501 (OR = 15.8, pc < 0.0001) and DQB1*0602 (OR = 19.8, pc < 0.0001) than in males (OR = 5.0 for both alleles; p = 0.012, pc = NS for DRB1 & p = 0.0012, pc = 0.017 for DQB1). The susceptibility alleles found in Mexicans with narcolepsy are also present in Japanese and Caucasians; DRB1*04 linked protection has also been shown in Koreans. A stronger HLA association is suggested in females, in accordance with the sexual dimorphism claimed previously.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 306 314 <span type="species:ncbi:9606">patients</span>
This knowledge may contribute to a better understanding of the disease pathogenesis in different populations. The evaluation of the risk to develop narcolepsy-cataplexy in carriers of the described alleles/genotypes may also be possible. A larger sample should be analysed in Mexican and in other Hispanic patients to confirm these results.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 282 283 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 801 802 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 920 921 920 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1046 1047 1046 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1125 1126 1125 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1304 1305 1304 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1340 1342 1340 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1508 1510 1508 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1769 1771 1769 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1967 1969 1967 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 938 946 <span type="species:ncbi:9606">patients</span>
###xml 1231 1239 <span type="species:ncbi:9606">patients</span>
###xml 1498 1506 <span type="species:ncbi:9606">patients</span>
Narcolepsy is a serious chronic neurological sleep disorder affecting between 0.02-0.05% of the general Caucasian population [1]. It is characterized by excessive daytime sleepiness, cataplexy, hypnagogic hallucination, sleep paralysis, and nocturnal fragmented/disorganized sleep [2,3]. Narcolepsy causes cognitive dysfunction, low academic performance and interpersonal problems [4]. Cataplexy is a pathognomonic clinical symptom required for the diagnosis of narcolepsy, according to the International Classification of Sleep Disorders [5]. It is a symptom that occurs when the muscle tension, in various areas of the body, is suddenly decreased involuntarily and lasts from few seconds to several minutes. Cataplexy is generally induced by laughter, excitement anger, and other emotional changes [5]. Mutations in genes of the hypocretin (orexin) neurotransmitter system cause narcoleptic symptoms in animal models [6]. Although most patients with narcolepsy-cataplexy have a reduction of hypocretin concentration in the cerebrospinal fluid [7], mutations or polymorphisms in hypocretin-related genes are extremely rare [8]. A potential autoimmune mechanism has been suggested, supported by the finding that in most narcolepsy patients, 80-90% of hypocretin cells in the hypothalamus were destroyed [9]. The lost of hypocretin neurons [10] has also been shown in a few post-mortem cases. In addition, the transcription of preprohypocretin mRNA was significantly decreased in the brain of these patients [11]. This wake-promoting neuropeptide is involved in sleep regulation, energy homeostasis, reward-seeking, learning, and memory; and it is also involved in the body temperature regulation, endocrine function, and the cardiovascular system, among other systems [12]. Recent studies also indicate that hypocretin/orexin neurons can alter their intrinsic electrical activity according to fluctuations in the levels of nutrients and appetite-regulating hormones [13].
###end p 11
###begin p 12
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 354 362 <span type="species:ncbi:9606">patients</span>
###xml 454 462 <span type="species:ncbi:9606">patients</span>
###xml 562 570 <span type="species:ncbi:9606">patients</span>
Narcolepsy transmission is polygenic, environmentally influenced and genetic factors play an important role in its expression. Family studies indicate the presence of a 20-40 times increased risk of disease expression in first-degree relatives, and monozygotic twin studies showed that concordance is partial (25-31%) [1]. Early onset French and Chinese patients suffering from narcolepsy have shown a positive family history as compared with late-onset patients [14,15], suggesting that the disease may be more likely due to genetic factors in this subgroup of patients.
###end p 12
###begin p 13
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
###xml 430 438 <span type="species:ncbi:9606">patients</span>
Based on the strong HLA association, family study segregation [16,17] and the finding of reduction of hypocretin-1 levels in the cerebrospinal fluid of DQB1*0602 positive patients [18,19], an autoimmune mediated destruction of hypothalamic neurons secreting hypocretin has been suggested as the cause of the disease. However, serum autoantibody markers have not been detected and no immunological abnormalities have been found in patients with narcolepsy [20].
###end p 13
###begin p 14
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQA1</italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQA1 </italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 300 304 300 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 738 742 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 822 826 822 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
###xml 674 682 <span type="species:ncbi:9606">patients</span>
The disease is strongly associated in Caucasians and Japanese with the DRB1*1501-DQA1*0102-DQB1*0602 haplotype. In African Americans, it is associated with DQB1*0602 haplotypes bearing different DRB1 alleles (*1101 and *1503) suggesting that DQA1 and DQB1 play a primary role in susceptibility [17]. DQB1*0602 rather than DRB1*1501 has been found increased in the patients, indicating that the disease susceptibility allele or locus is within, or, in the vicinity of the DQ region [21]. Haplotype analysis and contiguous genomic sequencing across the region have identified no other candidate gene [22]. Two-five fold increased risk in DQB1*0602 homozygous vs. heterozygote patients has been demonstrated in different ethnic groups [23]. DQB1*0301/*0602 carriers are also at an increased risk, whereas DQB1*0602/*0601 and DQB1*0602/*0501 heterozygotes have a lower disease risk [23-25].
###end p 14
###begin p 15
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
Several authors reported that 85 to 95% of patients with narcolepsy carry DQB1*0602 when cataplexy is clinically typical or severe. However, only 40-60% of the patients are DQB1*0602 when mild, atypical or no cataplexy exists [25,26]. TNF alpha region has also been claimed to be involved in susceptibility independently of class II loci [27].
###end p 15
###begin p 16
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT</italic>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COMT </italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
Genetic factors in other chromosomes have also been implicated [28]. A gender dimorphism and a strong effect of the catechol-O-methyltransferase (COMT) genes seem to influence symptoms. COMT genotype distribution between male and female patients was associated with the response to modafinil in Caucasians, since the optimal dose of modafinil was approximately 100 mg lower in females with narcolepsy, suggesting that females are better responders to the drug [29].
###end p 16
###begin p 17
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
The HLA genetic profile of Mexican and other Central American patients has not been published; therefore the aim of this study was to investigate the class II-DRB1/DQB1 allele distribution in a group of sporadic Mexican Mestizo patients with narcolepsy and to explore if the HLA association is gender related.
###end p 17
###begin title 18
Methods
###end title 18
###begin title 19
Subjects
###end title 19
###begin p 20
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 461 464 461 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1538 1540 1538 1540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1838 1840 1838 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1841 1843 1841 1843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 2458 2459 2458 2459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 100 107 <span type="species:ncbi:9606">patient</span>
###xml 412 423 <span type="species:ncbi:9606">participant</span>
###xml 736 743 <span type="species:ncbi:9606">patient</span>
###xml 772 780 <span type="species:ncbi:9606">patients</span>
###xml 997 1005 <span type="species:ncbi:9606">patients</span>
###xml 1351 1359 <span type="species:ncbi:9606">patients</span>
###xml 1850 1858 <span type="species:ncbi:9606">patients</span>
###xml 1947 1955 <span type="species:ncbi:9606">patients</span>
A total of 32 patients (14 males (45.17%) and 17 females (54.83%) were included. (The gender of one patient was unknown). All the cases were chosen and diagnosed based on the International Classification of Sleep Disorders (ICSD) [5] using clinical histories, nocturnal polysomnography, and Multiple Sleep Latency Tests. It is important to emphasize that the inclusion and exclusion criteria were given to every participant in the Narcolepsy Component of the 13th International Histocompatibility Workshop, and every centre must have used the same questionnaire and the same classification given by the experts [17]. The study was approved by the Ethics and Research Committees of each hospital. An informed consent was signed by every patient included in the study. Nine patients were selected from the Sleep Clinic at The Instituto Nacional de Neurologia in Mexico City, 12 were diagnosed at Stanford University Sleep Centre, and 11 were diagnosed at the Hospital Medica Sur in Mexico City. All patients were selected under exactly the same criteria in terms of ethnicity and diagnosis. Two hundred and three healthy controls belonging to the same population were included for comparison. These controls were all selected at the Department of Immunology and Immunogenetics in Mexico City and had no personal or family antecedents of narcolepsy. The patients and controls were all Mexican Mestizos defined according to the criteria of the Instituto de Investigaciones Antropologicas of the Universidad Nacional Autonoma de Mexico, UNAM [30]. All of them were Mexicans with at least parents, grandparents and great-grandparents born in Mexico; having Hispanic last names. Any individual with a non Hispanic background was excluded from the study. This ethnic group is the result of the admixture of Mediterranean, Black and Native genes [30,31]. The patients diagnosed in the USA followed exactly the same criteria, and most of them were in fact, patients from Mexico City from a previous collaborative done by Mignot E and Baker H. (Personal Communication). The controls were healthy subjects with no history of HLA confirmed associated diseases. Subjects with excessive daytime sleepiness, other sleep disorders, circadian or mental disorders, medication or substance abuse were carefully excluded. Each subject underwent a detailed clinical interview and completed a set of questionnaires according to The International Classification of Sleep Disorders [5].
###end p 20
###begin title 21
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
HLA-DRB1 &DQB1 typing
###end title 21
###begin p 22
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 741 746 741 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 866 871 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 875 880 875 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 225 232 <span type="species:ncbi:9606">patient</span>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
###xml 795 803 <span type="species:ncbi:9606">patients</span>
All patients and controls were typed at the Immunogenetics Department in Mexico City with the same technology and under the same technical conditions for each technique used. Ten mL peripheral EDTA blood were drawn from each patient coming from the Mexican Institutions. DNA was isolated using proteinase K digestion; purification was achieved with phenol chlorophorm and isopropanol was used for precipitation. DNA of patients diagnosed at Stanford University, were sent to our laboratory in Mexico City for HLA typing. DQB1 was typed on DNA samples from 32 patients, using a commercial kit based on Polymerase Chain Reaction and hybridization with membrane immobilized Sequence Specific Oligonucleotide Probes (PCR-SSOP reverse dot blot). DRB1 Sequence Based Typing (SBT) was performed in all patients using AlleleSEQR DRB1 kits, kindly donated by Atria Genetics. DRB1 and DQB1 alleles were typed in the control samples by PCR-SSOP using a chemiluminescent detection method designed for the 13th IHW (International Histocompatibility Workshop) [32].
###end p 22
###begin p 23
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 92 99 <span type="species:ncbi:9606">patient</span>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
DRB1 typing was performed in 27/32 samples because the amount of DNA was not enough. In one patient gender was unknown; therefore gender stratification analysis included only 31 patients.
###end p 23
###begin p 24
###xml 66 76 66 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
Haplotype assignment was done on the basis of the very well known DRB1-DQB1 linkage disequilibrium data published by us in Mexican Mestizos [31]. It was assumed that no blanks were present; when a single HLA allele was found; in this case, the subject was considered homozygous. Rare haplotype associations were taken into account, only when the complementary haplotype was perfectly defined.
###end p 24
###begin title 25
Statistical Analysis
###end title 25
###begin p 26
###xml 179 187 <span type="species:ncbi:9606">patients</span>
Allele frequency was calculated by direct counting. The Chi square test with Yates correction was used to assess the statistical difference of the HLA allele distribution between patients and controls. Bonferroni correction of the p value (pc) was done multiplying the p value by the number of comparisons made (equal to the number of tested alleles). This correction made more stringent the statistical significance of the results. Odds ratio (OR), was calculated when a significant association between the particular allele and the disease was found. Confidence interval (CI) (95%) was defined for every statistical deviation and is shown in each table. HLA related gender stratification was done using the SPSS 11 software.
###end p 26
###begin title 27
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Analysis of DQB1*0602 negative patients
###end title 27
###begin p 28
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 115 123 <span type="species:ncbi:9606">patients</span>
###xml 209 217 <span type="species:ncbi:9606">patients</span>
To assess whether HLA alleles, other than DQB1*0602 were associated with narcolepsy, the allelic frequency between patients and controls was compared, after taking out from the analysis the DQB1*0602 positive patients.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
HLA Association
###end title 30
###begin p 31
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 388 392 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 534 542 <span type="species:ncbi:9606">patients</span>
Only two DRB1 alleles were found significantly deviated in the patients (Table 1). DRB1*1501 was significantly increased (OR = 8.2; CI = 3.9-17.6; p < 0.0001; pc < 0.0001). The frequency of DRB1*0407 was significantly decreased in them (OR = 0.2; CI = 0.02-1.2; p = 0.016), although the significance was lost after Bonferroni correction. DQB1*0602 which is in linkage disequilibrium with DRB1*1501 was associated with susceptibility (OR = 8.4; CI = 4.3-16.6; p < 0.001; pc < 0.001) and the frequency of DQB1*0302 was decreased in the patients (Table 2).
###end p 31
###begin p 32
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
HLA-DRB1 distribution in Mexican Mestizo patients with narcolepsy and in healthy controls.
###end p 32
###begin p 33
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 217 223 217 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</bold>
###xml 256 261 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
AF: allele frequency; X2Y: Chi2 value with Yates correction; OR: Odds Ratio; CI: Confidence Interval; pc: Bonferroni correction (the p value was multiplied by the total number of alleles tested); NS: Not significant; dagger5/32 patients were not typed for DRB1 locus.
###end p 33
###begin p 34
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
HLA-DQB1 distribution in Mexican Mestizo patients with narcolepsy and in healthy controls.
###end p 34
###begin p 35
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
AF: allele frequency; X2Y: Chi2 value with Yates correction; OR: Odds Ratio; CI: Confidence Interval; pc: Bonferroni correction (the p value was multiplied by the total number of alleles tested); NS: Not significant.
###end p 35
###begin p 36
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 480 484 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 769 773 769 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
###xml 572 580 <span type="species:ncbi:9606">patients</span>
###xml 748 756 <span type="species:ncbi:9606">patients</span>
Upon withdrawal from the analysis of DQB1*0602 positive patients and controls, DQB1*0301 was found associated with the disease (Table 3) since 9/11 remaining patients were carriers of this allele (OR = 2.7; CI = 1.1-6.5; p = 0.0035; pc = Non significant (NS). We calculated the DQB1 genotype distribution in order to know the risk conferred by different combinations (Table 4). Only two genotypes were associated with narcolepsy: the highest risk was conferred by the combination DQB1*0602/DQB1*0301 (OR = 11.5; CI = 2.6-50.7; p = 0.00035), present in 15.6% (5/32) of the patients. DQB1*0602/X (excluding *0301) was also found significantly increased with a lower risk (OR = 9.5; CI = 4.1-21.9; p < 0.0001). This combination was positive in 50% of patients (16/32). No DQB1*0602 homozygotes were found.
###end p 36
###begin p 37
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
HLA-DQB1 distribution in Mexican Mestizo DQB1*0602 negative patients and controls.
###end p 37
###begin p 38
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 251 255 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 306 310 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 354 358 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
AF: allele frequency; X2Y: Chi2 value with Yates correction; OR: Odds Ratio; CI: Confidence Interval; pc: Bonferroni correction (the p value was multiplied by the total number of alleles tested); NS: Not significant; Lambda: 11/32 total patients were DQB1*0602 negative; sigma: 181/203 total controls were DQB1*0602 negative. ** this number includes two DQB1*0301 homozygotes.
###end p 38
###begin p 39
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
HLA-DQB1 genotypes distribution in Mexican Mestizo patients with narcolepsy and controls.
###end p 39
###begin p 40
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
GF: genotype frequency; X2Y: Chi2 value with Yates correction; OR: Odds Ratio; CI: Confidence Interval.
###end p 40
###begin title 41
Gender Stratification
###end title 41
###begin p 42
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 374 378 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
Although DRB1*1501 and DQB1*0602 were increased in both, females and males, the risk was higher in females: DRB1*1501 (OR = 15.8 CI = 4.5-55.7, p < 0.0001, pc < 0.0001 in females) vs. (OR = 5 CI = 1.6-15.4; p = 0.012, pc = NS in males) and DQB1*0602, (OR = 19.8, CI = 5.9-66.9, p < 0.0001, pc < 0.0001 in females) vs. (OR = 5, CI = 1.9-13, p = 0.0012, pc = 0.017 in males). DQB1*0302 was found significantly decreased only in males (OR = 0.3, CI = 0.1-1, p = 0.043, pc = NS).
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 560 564 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 565 570 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 824 828 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 862 866 862 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1043 1045 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1066 1071 1066 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 1105 1109 1105 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 1183 1188 1183 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 1221 1225 1221 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1292 1297 1292 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 1313 1318 1313 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 1399 1403 1399 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 1404 1409 1404 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 1450 1454 1450 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 1460 1464 1460 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1507 1511 1507 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1623 1627 1623 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 1633 1637 1633 1637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1655 1659 1655 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 1665 1669 1665 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1678 1682 1678 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 1696 1700 1696 1700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 1723 1727 1723 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1780 1782 1780 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1810 1812 1810 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1854 1858 1854 1858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1877 1881 1877 1881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 1989 1993 1989 1993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 2261 2265 2261 2265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 2271 2275 2271 2275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 2282 2286 2282 2286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 2292 2296 2292 2296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 2306 2310 2306 2310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 2316 2320 2316 2320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 2471 2473 2471 2473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 814 822 <span type="species:ncbi:9606">patients</span>
###xml 1077 1085 <span type="species:ncbi:9606">patients</span>
###xml 1194 1202 <span type="species:ncbi:9606">patients</span>
###xml 1303 1311 <span type="species:ncbi:9606">patients</span>
###xml 1526 1534 <span type="species:ncbi:9606">patients</span>
###xml 1610 1618 <span type="species:ncbi:9606">patients</span>
###xml 1754 1762 <span type="species:ncbi:9606">patients</span>
###xml 2032 2040 <span type="species:ncbi:9606">patients</span>
###xml 2405 2413 <span type="species:ncbi:9606">patients</span>
The results of this study are considered preliminary, due to the small sample size. However, it is important to mention that we are not "Hypothesis generating" but "hypothesis testing". As demonstrated by many statistician experts in the HLA field: "If an association is detected in the first case, it can be tested and confirmed in the latter without having to correct in multiple comparisons" [33]. Nevertheless, future studies in Hispanic admixed populations are needed to confirm the presence of other HLA allele associations. It is worth to mention, that DRB1/DQB1 association has been tested and repeatedly demonstrated by many authors in different ethnic groups [23-25,34]; therefore, the associations shown here, are real. In this study, we report on the genetic profile in a sample of narcoleptic Mestizo patients. DRB1*1501 (OR = 8.2; pc < 0.0001) and DQB1*0602 (OR = 8.4; pc < 0.0001) were the strongest associated alleles found in narcoleptic Mexicans, similarly to African, White Americans and different Oriental groups [23-25,34-37]. Fifteen of the 27 DRB1 typed patients, were positive for DRB1*1501 (allele frequency = 27.8 vs. 4.4% in the controls) and 21 of the 32 DQB1 typed patients were positive for DQB1*0602 (allele frequency = 32.8% vs. 5.4% in the controls). In five DQB1 typed patients, DRB1 was not typed because of insufficient DNA, thus we were not able to assemble the DRB1-DQB1 combinations in them. Interestingly, the DRB1*1501-DQB1*0602 haplotype was present in most of the DQB1*0602 positive patients but other DR2 allele combinations were also found. Indeed, two narcoleptic patients had DRB1*1502-DQB1*0602 and two had DRB1*1503-DQB1*0602. A DRB1*1503 but not DRB1*1502 association with DQB1*0602 has been reported in patients from Martinique [38] and in African Americans [23]. These results show, beyond doubt, that DQB1*0602, rather than DRB1*1501 is the major narcolepsy susceptibility allele in Mestizos. Interestingly, none of the DR52 associated-DQB1*0602 haplotypes were found in Mexican patients, but their frequency is low in the general healthy population. As an example, in 160 Mexican Mestizo healthy individuals typed in our laboratory, the haplotype frequency was 0.31% for each of the following combinations: DRB1*1101-DQB1*0602, DRB1*1201-DQB1*0602 and DRB1*1301-DQB1*0602 (unpublished data). Some of these haplotypes have been reported in narcoleptic patients in other populations, most notably in African Americans [23].
###end p 44
###begin p 45
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 115 123 <span type="species:ncbi:9606">patients</span>
###xml 252 260 <span type="species:ncbi:9606">patients</span>
###xml 541 549 <span type="species:ncbi:9606">patients</span>
No increase in DQB1*0602 homozygosity was found, as previously reported in White Americans and in African American patients, in whom a two to four fold higher risk has been described, compared to heterozygotes [23]. The same has been shown in Japanese patients [24]. This fact cannot be explained only based on the different allele frequencies of DQB1*0602 across ethnic groups, since the frequency shown in Japanese (AF = 6.4%) [24] was similar to the one found in the control group of the present study (AF = 5.5%). The lack of homozygote patients may be due to the reduced number of cases. Thus, again, a larger number is needed to confirm these results.
###end p 45
###begin p 46
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 496 500 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 704 709 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 767 771 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 775 779 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 887 891 887 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 897 901 897 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 977 981 977 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1161 1163 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 164 172 <span type="species:ncbi:9606">patients</span>
###xml 264 272 <span type="species:ncbi:9606">patients</span>
###xml 412 420 <span type="species:ncbi:9606">patients</span>
###xml 560 568 <span type="species:ncbi:9606">patients</span>
###xml 750 758 <span type="species:ncbi:9606">patients</span>
###xml 853 861 <span type="species:ncbi:9606">patients</span>
As in other populations, other DQB1 alleles, beside DQB1*0602, influence narcolepsy susceptibility [24,39]. The analysis of DQB1 distribution in DQB1*0602 negative patients showed that DQB1*0301 (OR = 2.7, p = 0.03) was significantly increased in this subgroup of patients. DQB1*0301 had also the second strongest susceptibility effect, after DQB1*0602 in Africans, Japanese and White Americans [24]. In Mexican patients, DQB1*0301 occurred in the context of several HLA haplotypes that included DRB1*1101, *1303, *1304, *0806 and *1602; however the number of patients in this group was insufficient to perform additional comparisons and to explain the possible independent contribution of the mentioned DRB1 alleles to susceptibility. None of these patients had the DRB1*04-DQB1*0301, found associated in White Americans [24]. Genotype distribution in patients and controls showed that DQB1*0602/DQB1*0301 conferred the highest risk for susceptibility (OR = 11.4) compared to DQB1*0602/X (non *0301) (OR = 9.4). The former combination was also described as the one with the highest risk for the development of narcolepsy, across three different ethnic groups [24].
###end p 46
###begin p 47
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 601 605 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 694 698 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 965 969 965 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 1011 1015 1011 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1237 1239 1237 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1415 1417 1415 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1418 1420 1418 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1421 1423 1421 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1424 1426 1424 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1427 1429 1427 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
###xml 591 599 <span type="species:ncbi:9606">patients</span>
DRB1*0407, which is the most frequent allele in Mexican population, seemed to be linked to protection in the present study. This allele is in strong linkage disequilibrium with DQB1*0302 in Mexicans and the haplotype frequency of DRB1*0407-DQB1*0302 is 13.1% [31]. In Koreans DRB1*0406-DQB1*0302 was found protective in patients with narcolepsy [39]. None of these studies confirmed a possible effect of DRB1*04 in susceptibility as previously shown in Whites and Japanese [24]. It may be claimed that the DQB1 locus may also be involved in protection, since in Korean as well as in Mexican patients, DQB1*0302 was decreased, although combined with *0406 in Koreans and with *0407 in Mexicans. DQB1*0601 has also been associated with protection in Koreans [25,39] and Japanese [40], but the latter was not related with protection in Mexicans, perhaps due to its low frequency (AF = 0.5%) [31]. Similar findings have been published recently in Koreans, where again, DRB1*0406 was found negatively associated and DQB1*0301 was described as a susceptibility allele. The authors claim based on their own work, and previous work, that a remarkable consistency of the HLA association pattern across multiple ethnic groups and cultures exists [41]. Thus, even if our sample size is small and the results of protection and secondary association may be regarded as preliminary, our data are consistent with those published [21,23-26,39,41].
###end p 47
###begin p 48
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 707 711 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 917 921 917 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
###xml 588 594 <span type="species:ncbi:9606">people</span>
###xml 945 953 <span type="species:ncbi:9606">patients</span>
###xml 1038 1046 <span type="species:ncbi:9606">patients</span>
Interestingly, the overall positive rate for DQB1*0602 in Mexican patients was 65.6%, while in Japanese, White Americans and African Americans; the rate is between 75-80% [24]. To analyse if this difference was significant or not, we performed a statistical comparison between patients and controls from the present study and those from the Mignot et al. study [24]. No significant difference, regarding DQB1*0602 distribution, was found between Japanese and Mexican controls but we did find a significant deviation when comparing Mexican controls with White or African Americans healthy people (p = 0.001 and p = 0.00000001, respectively). These differences are due, undoubtedly, to the lower frequency of DQB1*0602 existing in the general Mexican population [42], which is similar to the one found in Orientals, but it is lower than the frequency in Caucasian and African Americans [43]. The lower frequency of the DQB1*0602 allele in Mexican patients compared with African (p = 0.0007), Caucasian (p = 0.003) and Japanese (p = 0.0009) patients, is due to our small number of cases.
###end p 48
###begin p 49
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 499 509 499 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602 </italic>
###xml 593 594 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 803 807 803 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 842 846 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 1292 1296 1292 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 1297 1302 1297 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 1574 1576 1574 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 460 468 <span type="species:ncbi:9606">patients</span>
###xml 907 915 <span type="species:ncbi:9606">patients</span>
###xml 1550 1555 <span type="species:ncbi:9606">women</span>
Gender stratification showed a differential distribution of DRB1 and DQB1 alleles. The patients selection was unbiased since no significant difference was found when distribution of males Vs. females was compared (Z = 0.561, p = 0.29). To demonstrate if the gender selection among the controls was biased, we performed several analyses comparing the mean allele frequency in the overall control group with the frequency for HLA DQB1*0602 among male and female patients. However, the distribution of DQB1*0602 alleles among female and male controls was found in the limit of the significance (X2Y = 3.841, p = 0.05; data not shown). Therefore, it must be mentioned that even if the p value was p = 0.05, the control selection may have been biased. When HLA distribution was compared matching for gender, DRB1*1501 (OR = 15.8; pc < 0.0001) and DQB1*0602 (OR = 19.8; p < 0.0001) showed a higher risk in female patients, although the same alleles were significantly increased in males, but with less intensity. This stronger female HLA association was described for the first time. However, it is important to confirm these data with a larger sample size and in different ethnic groups. Thus, the gender association reported here should be regarded as preliminary. Even if we have a stronger HLA DRB1/DQB1 association in females, this does not imply, by any means, that females are more or less affected than males; this only means that there is a stronger HLA genetic predisposition to narcolepsy in females than in males. A better response in affected women to certain drugs [29] is not contradictory at all, with the HLA/female association.
###end p 49
###begin p 50
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 378 381 <span type="species:ncbi:9606">men</span>
###xml 480 485 <span type="species:ncbi:10090">mouse</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
The explanation for this gender specific association is not clear, but a sexual dimorphism and a strong effect of the COMT genotype on disease severity and response to modafinil have been shown [44]. Females with narcolepsy with high COMT activity fell asleep twice as fast as those with low COMT activity during the multiple sleep latency test, while the opposite was true for men [45]. A gender difference in body weight gain and leptin signaling in hypocretin/orexin deficient mouse models has been also claimed [46]. Obesity was more prominent in females in both preprohypocretin knockout mice and orexin/ataxin-3 transgenic narcoleptic mice and was associated with higher serum leptin levels, suggesting a partial leptin resistance [46].
###end p 50
###begin title 51
Conclusion
###end title 51
###begin p 52
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
In conclusion, this is the first study reported in Mexican patients with narcolepsy-cataplexy; the profile of HLA class II allele associations was found to be complex. As in other diseases such as type I diabetes, multiple sclerosis and others, studied by our group in Mexican Mestizos, the HLA pattern in these diseases was somewhat distinct from the association typically found in Caucasians or Blacks and Orientals [47,48], illustrating the importance of analysing MHC associations in populations with different ethnic backgrounds. We also demonstrated an HLA associated sexual dimorphism in this population and a protective allele effect which was also shown in some Oriental populations. Insights on the different HLA associations in different ethnic groups may prove to be an important asset in the investigation of genetic factors and the molecular mechanisms of disease expression. This knowledge may be important for the design of predictive, therapeutic and perhaps preventive approaches.
###end p 52
###begin title 53
Competing interests
###end title 53
###begin p 54
The authors declare that they have no competing interests.
###end p 54
###begin title 55
Authors' contributions
###end title 55
###begin p 56
CA Drafted the manuscript and supervised the laboratory work. LL Collaborated in drafting the manuscript and extracted the DNA at Stanford University. HF-A Carry out the statistical analysis and revised the drafted manuscript. MV Collaborated with the technical HLA DNA typing and revised the drafted manuscript. AM Collaborated with the technical HLA DNA typing and revised the drafted manuscript. EM Selected the clinical cases and wrote the criteria for all Centres and for the 13th International Histocompatibility Workshop and revised the drafted manuscript. RH Diagnosed and selected the cases from The Instituto Nacional de Neurologia and revised the drafted manuscript. HB Diagnosed and selected the cases from and revised the drafted manuscript. CG Coordinated all the work, revised the results and statistical analysis, revised the drafted manuscript thoroughly; revised and corrected the final version. All authors read and approved the final manuscript.
###end p 56
###begin title 57
Pre-publication history
###end title 57
###begin p 58
The pre-publication history for this paper can be accessed here:
###end p 58
###begin p 59

###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
###xml 182 189 <span type="species:ncbi:9606">patient</span>
We are truly grateful to the organizers of the disease component of the 13th International Histocompatibility Workshop of the Narcolepsy Working Group for providing the criteria for patient selection and to the Technology Component for providing the primers and probes HLA sequences. The study was performed with the financial support of Fundacion Comparte Vida A.C. and of The Instituto de Diagnostico y Referencia Epidemiologicos in Mexico City. We are also grateful for the technical support of Felicitas Manzanares. We are in indebted to Atria Genetics for contributing with the SBT reagents.
###end p 61
###begin article-title 62
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Frequency of narcolepsy symptoms and other sleep disorders in narcoleptic patients and their first-degree relatives
###end article-title 62
###begin article-title 63
Narcolepsy
###end article-title 63
###begin article-title 64
Narcolepsy
###end article-title 64
###begin article-title 65
Prevalence of narcolepsy-cataplexy in Korean adolescents
###end article-title 65
###begin article-title 66
Genetic studies in the sleep disorder narcolepsy
###end article-title 66
###begin article-title 67
###xml 34 39 <span type="species:ncbi:9606">human</span>
Hypocretin (orexin) deficiency in human narcolepsy
###end article-title 67
###begin article-title 68
The genetics of narcolepsy
###end article-title 68
###begin article-title 69
###xml 40 45 <span type="species:ncbi:9606">human</span>
Reduced number of hypocretin neurons in human narcolepsy
###end article-title 69
###begin article-title 70
###xml 23 28 <span type="species:ncbi:9606">human</span>
Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy
###end article-title 70
###begin article-title 71
###xml 99 104 <span type="species:ncbi:9606">human</span>
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
###end article-title 71
###begin article-title 72
Neurons containing hypocretin (orexin) project to multiple neuronal systems
###end article-title 72
###begin article-title 73
Metabolic state signalling through central hypocretin/orexin neurons
###end article-title 73
###begin article-title 74
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Age at onset of narcolepsy in two large populations of patients in France and Quebec
###end article-title 74
###begin article-title 75
Clinical features of early-onset narcolepsy
###end article-title 75
###begin article-title 76
###xml 36 41 <span type="species:ncbi:9606">human</span>
Genome wide association analysis of human narcolepsy and a new resistance gene
###end article-title 76
###begin article-title 77
###xml 6 9 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
The 13th International Histocompatibility Working Group for Narcolepsy Joint Report
###end article-title 77
###begin article-title 78
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias
###end article-title 78
###begin article-title 79
###xml 72 79 <span type="species:ncbi:9606">patient</span>
Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy
###end article-title 79
###begin article-title 80
Narcolepsy and immunity
###end article-title 80
###begin article-title 81
DQ (rather than DR) gene marks susceptibility to narcolepsy
###end article-title 81
###begin article-title 82
HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy
###end article-title 82
###begin article-title 83
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
HLA-DQB1 *0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group
###end article-title 83
###begin article-title 84
Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups
###end article-title 84
###begin article-title 85
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy
###end article-title 85
###begin article-title 86
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
HLA DQB1 *0602 is associated with cataplexy in 509 narcoleptic patients
###end article-title 86
###begin article-title 87
###xml 126 131 <span type="species:ncbi:9606">human</span>
Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy
###end article-title 87
###begin article-title 88
Screening for candidate gene regions in narcolepsy using a microsatellite based approach and pooled DNA
###end article-title 88
###begin article-title 89
Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil
###end article-title 89
###begin article-title 90
Mestizaje e historia de la poblacion en Mexico
###end article-title 90
###begin article-title 91
The genetic structure of Mexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites
###end article-title 91
###begin article-title 92
Identification of candidate genes in the HLA complex (MHC) contributing to susceptibility and/or protection from diseases: Typing methods for Microsatellite(s) markers
###end article-title 92
###begin article-title 93
HLA and disease association: statistical considerations
###end article-title 93
###begin article-title 94
###xml 58 66 <span type="species:ncbi:9606">patients</span>
The familial risk and HLA susceptibility among narcolepsy patients in Hong Kong Chinese
###end article-title 94
###begin article-title 95
Narcolepsy and HLA in the Japanese
###end article-title 95
###begin article-title 96
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQA1</italic>
DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasians and black Americans
###end article-title 96
###begin article-title 97
The prevalence of narcolepsy among Chinese in Hong Kong
###end article-title 97
###begin article-title 98
Severity of narcolepsy among French of different ethnic origins (south of France and Martinique)
###end article-title 98
###begin article-title 99
###xml 37 45 <span type="species:ncbi:9606">patients</span>
HLA and hypocretin studies in Korean patients with narcolepsy
###end article-title 99
###begin article-title 100
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 68 73 <span type="species:ncbi:9606">human</span>
Negative association of the HLA-DRB1 *1502-DQB1*0601 haplotype with human narcolepsy
###end article-title 100
###begin article-title 101
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
DQB1 *0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans
###end article-title 101
###begin article-title 102
HLA Class I/II Diversity In The Mexican Bone Marrow Registry - DONORMO: Analysis of 3497 Volunteers [abstract]
###end article-title 102
###begin article-title 103
Pharmacogenomics in the treatment of narcolepsy
###end article-title 103
###begin article-title 104
MAO-A and COMT polymorphisms and gene effects in narcolepsy
###end article-title 104
###begin article-title 105
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Sex difference in body weight gain and leptin signaling in hypocretin/orexin deficient mouse models
###end article-title 105
###begin article-title 106
HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example
###end article-title 106
###begin article-title 107
Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans
###end article-title 107

